Disclaimer:
This blog is for informational purposes only and should not be taken as medical advice. Content is sourced from third parties, and we do not guarantee accuracy or accept any liability for its use. Always consult a qualified healthcare professional for medical guidance.
Tongue cancer, a subset of oral cavity cancer, arises in the tongue’s squamous cells, divided into oral tongue (anterior two-thirds, 70%) and base of tongue (posterior, HPV-related). It’s primarily squamous cell carcinoma, with ~17,000 US cases annually in 2025 (part of oral cancers), more in men aged 60+. Often aggressive, it spreads to lymph nodes early, impacting speech and swallowing.
Symptoms include a persistent sore/ulcer on the tongue, red/white patches, pain (worsened by eating/spicy foods), difficulty swallowing/speaking, tongue stiffness, neck lump (lymph nodes), ear pain, bad breath, and bleeding. Advanced cases cause weight loss, slurred speech, or airway obstruction. Symptoms mimic ulcers or infections, delaying diagnosis.
Risk factors include smoking (3-5 times risk), heavy alcohol (synergistic), HPV (base of tongue, 50% of cases), poor oral hygiene, betel nut chewing, and chronic irritation (sharp teeth). TP53 and EGFR mutations drive growth. In 2025, HPV vaccination reduces base-of-tongue incidence, but tobacco persists as a driver.
Diagnosis involves oral exam, flexible endoscopy, biopsy, and imaging (CT/MRI/PET). HPV testing stratifies prognosis. In 2025, AI endoscopy and molecular profiling enhance detection.
Early-stage uses surgery (partial glossectomy) or radiation. Advanced cases combine surgery, IMRT, and chemotherapy (cisplatin). Immunotherapy (pembrolizumab) for HPV+ or recurrent cases. In 2025, robotic surgery improves speech/swallowing outcomes.
In 2025, 5-year survival is 80% for localized, 40% for metastatic. HPV+ cases fare better (90%). By 2030, vaccines and targeted therapies could achieve 85% survival.
Cleveland Clinic’s “Tongue Cancer: Symptoms, Causes & Treatment”; Mayo Clinic’s “Tongue cancer – Symptoms and causes”; NCI’s “Oral Cavity and Oropharyngeal Cancer Treatment (PDQ®)”; American Cancer Society’s “Oral and Oropharyngeal Cancer”; PMC’s “Tongue Cancer: 2025 Updates”.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
1. Scan at your preferred center.
2. Written report from a specialist radiologist sent via email.
3. Access and download your scan images digitally.
4. Upon request, we can send the report and images to your doctor or hospital.
5. For self-referred patients, there is an additional charge of £30, which includes scan referral and a discussion with a private GP before and after the scan